Company: HQL
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001104659-25-034659
Chunk: 19

Company: abrdn Life Sciences Investors
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 19
---
 11.36 | % |

* These entities jointly filed a Schedule 13D for the share amount and percentage shown. Shareholder Proposals. Any Rule 14a-8 shareholder proposal to be considered for inclusion in the Funds' proxy statement and form of proxy for the annual meetings of shareholders to be held in 2026 should be received by the Secretary of the Funds no later than December 15, 2025. There are additional requirements regarding proposals of shareholders, and a shareholder contemplating submission of a proposal for inclusion in the Funds' proxy materials is referred to Rule 14a-8 under the 1934 Act. In addition, shareholder proposals for each Fund's 2025 Annual Meeting (other than proposals submitted for inclusion in the Fund's 2026 proxy statement pursuant to Rule 14a-8) must be submitted to the Fund's Secretary between January 28, 2026 and February 27, 2026, unless the meeting date is more than 30 days before or after May 28, 2026, in which case the proposal must be submitted by the later of the close of business on (1) the date 90 days prior to the 2026 Annual Meeting date or (2) the tenth business day following the date on which the 2026 Annual Meeting date is first publicly announced or disclosed. In accordance with Rule 14a-4(c), each Fund may exercise discretionary voting authority with respect to any shareholder proposals for the Annual Meetings not included in the proxy statement and form of proxy card which are not submitted to the Funds within the time-frame indicated above. Even if timely notice is received, a Fund may exercise discretionary voting authority in certain other circumstances permitted by Rule 14a-4(c) and SEC guidance related thereto. Discretionary voting authority is the ability to vote proxies that shareholders have executed and returned to a Fund on matters not specifically reflected on the form of proxy card. SHAREHOLDERS WHO DO NOT EXPECT TO ATTEND THE MEETINGS AND WHO WISH TO HAVE THEIR SHARES VOTED ARE REQUESTED TO DATE AND SIGN THE ENCLOSED PROXY CARD(S) AND RETURN THEM IN THE ENCLOSED ENVELOPE. NO POSTAGE IS REQUIRED IF MAILED IN THE UNITED STATES.

<div align='center'>19</div>

Delivery of Joint Proxy Statement

Unless the Funds have received contrary instructions from shareholders, only one copy of this Joint Proxy Statement may be mailed to households, even if more than one person in a household is a shareholder